Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | APABLAZA, GASTON |
| Género | Hombre |
| Área Principal WOS | Chemistry, Multidisciplinary; Biochemistry & Molecular Biology; Chemistry, Organic; |
| Afiliación Principal | Universidad De Valparaíso |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Chemistry, Multidisciplinary | 1 |
| Biochemistry & Molecular Biology | 1 |
| Chemistry, Organic | 1 |
| Scopus | #Pub |
|---|
| SciELO | #Pub |
|---|
| Autor | Género | # Pub |
|---|---|---|
| MELLA-RAIPÁN, JAIME | Hombre | 1 |
| CUELLAR-FRITIS, MAURICIO | Hombre | 1 |
| LAGOS-AREVALO, CARLOS FERNANDO | Hombre | 1 |
| MONTOYA, LUISA | Mujer | 1 |
| CHUNG, HERY | - | 1 |
| MORALES-VERDEJO, CESAR AARON | Hombre | 1 |
| MELLADO-GARCIA, MARCO ANDRES | Hombre | 1 |
| SOTO-DELGADO, JORGE | Hombre | 1 |
| PESSOA-MAHANA, CARLOS DAVID | Hombre | 1 |
| Año | Firma | Institución (Incites asoc.) | H Index | Average Percentile | Impact Citation | Impact Relative World | Impact Journal Normalized Citation | Impact Category Normalized Citation | Percentage Cited | Percentage Top 1 | Percentage Top 10 | Percentage Journal Q1 | Percentage Journal Q2 | Percentage Journal Q3 | Percentage Journal Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | Apablaza, Gaston | Universidad de Valparaiso | 1.0 | 58.8 | 3.0 | 0.3 | 0.9 | 0.4 | 100.0 | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 | 0.0 |
| Título | Año | Citas | Tipo | Revista | Indexada |
|---|---|---|---|---|---|
| 2 D Qsar And 3 D Qsar/Co Msia Studies On A Series Of (R) 2 ((2 (1 H Indol 2 Yl)ethyl)amino) 1 Phenylethan 1 Ol With Human Beta(3) Adrenergic Activity | 2017 | 13 | artículo de investigación | Molecules | WoS Scopus |
| Palabra Clave | #Pub |
|---|---|
| human-immunodeficiency-virus-(i) protease inhibitors | 1 |
| vibegron | 1 |
| urinary-bladder | 1 |
| qsar | 1 |
| potent human | 1 |
| obesity | 1 |
| molecular biological evidence | 1 |
| mirabegron | 1 |
| indole | 1 |
| 3-dimensional qsar | 1 |
| human beta-3-adrenergic receptor | 1 |
| discovery | 1 |
| diabetes | 1 |
| derivatives | 1 |
| comsia | 1 |
| beta-3 adrenergic receptor | 1 |
| atypical beta-adrenoceptors | 1 |
| agonists | 1 |